|
|
Volumn 6, Issue 5, 2005, Pages 266-
|
|
Bevacizumab and chemotherapy improves survival in NSCLC
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CARBOPLATIN;
ERLOTINIB;
PACLITAXEL;
VASCULOTROPIN;
ANTIANGIOGENIC ACTIVITY;
BLEEDING;
BLOOD CLOTTING DISORDER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INHIBITION;
CLINICAL TRIAL;
COLORECTAL CANCER;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LUNG CANCER;
LUNG HEMORRHAGE;
LUNG NON SMALL CELL CANCER;
METASTASIS;
NOTE;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
SURVIVAL TIME;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 17844379201
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(05)70155-8 Document Type: Note |
|
Times cited : (17)
|
|
References (0)
|